Skip to main content

Table 1 Patient Characteristics and Treatment Options

From: Successful management of concurrent COVID-19 and Pneumocystis Jirovecii Pneumonia in kidney transplant recipients: a case series

Variables

Case 1

Case 2

Case 3

Case 4

Sex

M

M

M

F

Age (years)

65

27

52

66

Months post-Tx

144

27

79

81

Vital signs

    

SpO2

90%

91%

89%

89%

Signs/symptoms

    

Fever (T > 37.5 °C)

39.2℃

39.0℃

39.7℃

39.0℃

Cough

Yes

Yes

Yes

Yes

Diarrhea

Yes

Yes

Yes

Yes

Chest tightness

Yes

Yes

Yes

Yes

Weak

Yes

Yes

Yes

Yes

CT (Lung infection)

Yes

Yes

Yes

Yes

Immunosuppressive Regimen at admission

MMF/FK/PDN

MMF/FK/PDN

MMF/FK/PDN

MMF/FK/PDN

Treatment

MPSL/ NTV/RIT/ GCV/ SMX/ CAS/ MXF

MPSL/ NTV/RIT/ GCV/ SMX/ CAS/ MXF

MPSL/ NTV/RIT/ GCV/ SMX/ CAS/ MXF

MPSL/ NTV/RIT/ GCV/ SMX/ CAS/ MXF

  1. CT, Computerized Tomography; MMF, mycophenolate mofetil; FK, tacrolimus; PDN, prednisone; MPSL, Methylprednisolone; NTV/RIT, Naimatevir/Ritonavir combination; GCV, Ganciclovir; SMX, Sulfamethoxazole; CAS, Caspofungin; MXF, Moxifloxacin